News

FILTER BY:
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Announcement regarding filing of Annual Report on Form 20-F with the U.S. Securities and Exchange CommissionAnnouncement regarding filing of Annual Report on Form 20-F with the U.S. Securities and Exchange Commission
Press Release

Announcement regarding filing of Annual Report on Form 20-F with the U.S. Securities and Exchange Commission

June 29, 2023
2023 Forbes Iconoclast Summit: Titans Of Investing2023 Forbes Iconoclast Summit: Titans Of Investing
News

2023 Forbes Iconoclast Summit: Titans Of Investing

June 26, 2023
Mizuho investment banking head Katz tells grads: Don’t just play for table stakesMizuho investment banking head Katz tells grads: Don’t just play for table stakes
News

Mizuho investment banking head Katz tells grads: Don’t just play for table stakes

June 21, 2023
Here’s why retail traders are moving away from coinbase and into robinhoodHere’s why retail traders are moving away from coinbase and into robinhood
News

Here’s why retail traders are moving away from coinbase and into robinhood

June 16, 2023
Utilities have underperformed this year, but earnings look promisingUtilities have underperformed this year, but earnings look promising
News

Utilities have underperformed this year, but earnings look promising

June 15, 2023
Forbes Iconoclast Summit 2023: Wisdom From The World’s Most Influential InvestorsForbes Iconoclast Summit 2023: Wisdom From The World’s Most Influential Investors
News

Forbes Iconoclast Summit 2023: Wisdom From The World’s Most Influential Investors

June 14, 2023
Biogen has been an ‘uninvestable’ stock for awhile, says Mizuho’s Jared HolzBiogen has been an ‘uninvestable’ stock for awhile, says Mizuho’s Jared Holz
News

Biogen has been an ‘uninvestable’ stock for awhile, says Mizuho’s Jared Holz

June 14, 2023
Vijay Rakesh on Bloomberg Markets (Starts at 12:55)Vijay Rakesh on Bloomberg Markets (Starts at 12:55)
News

Vijay Rakesh on Bloomberg Markets (Starts at 12:55)

June 10, 2023
Merck’s challenge to medicare drug pricing could cause ‘narrative shift’ in pharma, says Jared HolzMerck’s challenge to medicare drug pricing could cause ‘narrative shift’ in pharma, says Jared Holz
News

Merck’s challenge to medicare drug pricing could cause ‘narrative shift’ in pharma, says Jared Holz

June 7, 2023
back-to-top-blue